Exploiting dendritic cells for cancer im
โ
Karine Breckpot; Carlo Heirman; Bart Neyns; Kris Thielemans
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 579 KB
## Abstract Dendritic cells (DCs) are pivotal regulators of immune reactivity and immune tolerance. The observation that DCs can recruit naive T cells has invigorated cancer immunology and led to the proposal of DCs as the basis for vaccines designed for the treatment of cancer. Designing effective